The laboratory industry is entering a period of major operational and financial change. Recent CMS and FDA regulatory updates are beginning to reshape how laboratories manage compliance, billing, and reimbursement, and the effects are not theoretical. For many labs, increased denials, delayed reimbursements, expanded documentation requests, and tighter payer scrutiny are already showing up in the numbers.
Clinical laboratories are operating in a much tighter enforcement environment than they were a few years ago. The Department of Justice continues to focus on healthcare fraud, False Claims Act liability, kickback arrangements, medically unnecessary testing, and billing patterns that suggest revenue is being generated without enough compliance control behind it.
The Importance of Patient Engagement: Why They - And You - Need It
Learn why patient engagement is a necessity and how you can master it within your practice.
Medical Billing / RCM | Laboratory
For clinical laboratories, compliance risk is no longer confined to the legal department. It is now a core financial, operational, and enterprise risk.
Medical Billing / RCM | Laboratory
Laboratory reimbursement is back in the spotlight and the stakes are higher than ever before.
Medical Billing / RCM | Laboratory
If there’s one frustration nearly every healthcare organization shares in 2026, it’s this:
Medical Billing / RCM | Laboratory
For years, patient financial engagement was treated as a collections problem. In 2026, that framing is officially outdated.
Medical Billing / RCM | Laboratory
Laboratory revenue cycle management has never been simple — but in 2026, it has become structurally harder.